BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4465345)

  • 1. Vinca alkaloids XXXIII [1]. Microbiological conversions of vincaleukoblastine (VLB, vinblastine), an antitumor alkaloid from Vinca rosea. Linn.
    Neuss N; Mallett GE; Brannon DR; Mabe JA; Horton HR; Huckstep LL
    Helv Chim Acta; 1974; 57(6):1886-90. PubMed ID: 4465345
    [No Abstract]   [Full Text] [Related]  

  • 2. Vinca alkaloids. XXXII. Microbiological conversions of vindoline, a major alkaloid from Vinca rosea L.
    Neuss N; Fukuda DS; Mallett GE; Brannon DR; Huckstep LL
    Helv Chim Acta; 1973 Jul; 56(7):2418-26. PubMed ID: 4761279
    [No Abstract]   [Full Text] [Related]  

  • 3. Vince alkaloids XXXIV). Preparation of des-Na-methyl-vindoline by microbiological conversion of vindoline, a major alkaloid from Vinca rosea L.
    Neuss N; Fukuda DS; Brannon DR; Huckstep LL
    Helv Chim Acta; 1974; 57(6):1891-3. PubMed ID: 4465346
    [No Abstract]   [Full Text] [Related]  

  • 4. [RESEARCH ON THE CYTO-PHARMACOLOGICAL EFFECTS OF VINCALEUKOBLASTINE (VLB), ALKALOID OF VINCA ROSEA L., ON EMBRYONAL ERYTHROPOIETIC CELLS].
    RONDANELLI R; MAGLIULO E; CULTRERA G; CAVALLI G
    G Ital Chemioter; 1964; 11():108-18. PubMed ID: 14279685
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action.
    CUTTS JH; BEER CT; NOBLE RL
    Cancer Res; 1960 Aug; 20():1023-31. PubMed ID: 13719013
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.
    JOHNSON IS; WRIGHT HF; SVOBODA GH; VLANTIS J
    Cancer Res; 1960 Aug; 20():1016-22. PubMed ID: 14407465
    [No Abstract]   [Full Text] [Related]  

  • 7. Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.
    WARWICK OH; DARTE JM; BROWN TC; BEER CT; CUTTS JH; NOBLE RL
    Cancer Res; 1960 Aug; 20():1032-40. PubMed ID: 13842983
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alkaloids of Vinca rosea L. introduced to Western Georgia].
    Vachnadze NS; Kintsurashvili LG; Suladze TSh; Bakuridze AD; Vachnadze VIu
    Georgian Med News; 2013 Nov; (224):85-8. PubMed ID: 24323972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKALOIDS OF VINCA ROSEA LINN. (CATHARANTHUS ROSEUS G. DON). XXIV. VINASPINE, VINCATHICINE, ROVIDINE, DESACETYL VLB, AND VINAPHAMINE.
    SVOBODA GH; BARNES AJ
    J Pharm Sci; 1964 Oct; 53():1227-31. PubMed ID: 14249445
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
    Ono M; Tanaka N
    In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial transformations of natural antitumor agents XVIII: Conversions of vindoline with copper oxidases.
    Eckenrode F; Peczynska-Czoch W; Rosazza JP
    J Pharm Sci; 1982 Nov; 71(11):1246-50. PubMed ID: 7175717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don). XV. Analysis of vinca alkaloids by thin-layer chromatography.
    CONE NJ; MILLER R; NEUSS N
    J Pharm Sci; 1963 Jul; 52():688-92. PubMed ID: 14022560
    [No Abstract]   [Full Text] [Related]  

  • 14. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
    Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
    In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of viral infection on the content of vincaleukoblastine of Vinca rosea L., as well as on the morphologic and anatomic characteristics of this plant].
    Gheorghiu A; Ionescu-Matiu E
    Ann Pharm Fr; 1967 Dec; 25(12):807-16. PubMed ID: 5611062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.